---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-034737"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:36:49.814564+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Glucotrack appoints CEO Paul Goode and biotech veteran John Ballantyne to Board of Directors

## Summary
- CEO Paul V. Goode appointed as a board member, effective August 27, 2024.
- John Ballantyne, former Aldevron co-founder and CSO, appointed to board effective immediately.
- Ballantyne brings 20+ years biotech experience; served as CSO through Danaher acquisition.
- Ballantyne's background expected to aid commercialization of Glucotrack's implantable CGM technology.

## SEC filing metadata
- accession: 0001493152-24-034737
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315224034737/0001493152-24-034737-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315224034737/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-034737
- JSON: https://secwatch.observer/filing/0001493152-24-034737.json
- Plain text: https://secwatch.observer/filing/0001493152-24-034737.txt

## Key facts
- Executive change
  Paul V. Goode was appointed as director at Glucotrack, Inc..
  - Action: appointed
  - Role: director
  source text: On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315224034737/0001493152-24-034737-index.htm
- Executive change
  John Ballantyne was appointed as director at Glucotrack, Inc..
  - Action: appointed
  - Role: director
  source text: On August 27, 2024, the Board of Directors of Glucotrack, Inc. (the “Company”) appointed Paul V. Goode, and Mr. John Ballantyne to the Board of Directors (the “Board”) as board members.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315224034737/0001493152-24-034737-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.